In the past decade, GH has gained extensive attention in tumour development, progression and metastasis, including breast cancer,2 prostate cancer,3 endometrial cancer,4 hepatocellular carcinoma 5 and gastric cancer.6 This evidence concerns the gene GH1 and breast carcinoma.